Polatuzumab Vedotin for Relapsed/Refractory Aggressive B-Cell Lymphoma: A Multicenter Post-Marketing Analysis

Publication date: Available online 18 December 2020Source: Clinical Lymphoma Myeloma and LeukemiaAuthor(s): S.D. Smith, P. Lopedote, Y. Samara, M. Mei, A.F. Herrera, A. Winter, B.T. Hill, M. Shadman, C. Ujjani, R.C. Lynch, C.A. Jacobson, A.I. Kim, P. Caimi, F. Milano, A.K. Gopal
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research